Gossamer Bio (GOSS) vs Rein Therapeutics (RNTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rein Therapeutics (RNTX) has outperformed Gossamer Bio (GOSS) over the past year, losing 45.2% versus a loss of 94.9%. Over five years, RNTX leads with a -96.1% price change compared with -99.1% for GOSS. Rein Therapeutics is the larger company by market cap ($66.4 million vs $60.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GOSS | RNTX |
|---|---|---|
| Share price | $9.88 | $0.7693 |
| Market cap | $60.43M | $66.37M |
| 1-day change | -2.95% | -2.46% |
| YTD return | -95.90% | -32.01% |
| 1-year return | -94.91% | -45.23% |
| 5-year return | -99.10% | -96.10% |
| EPS (TTM) | $-52.80 | $-1.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $309.60 | $2.18 |
| 52-week low | $9.12 | $0.694 |
| Distance from 52-week high | -96.81% | -64.71% |
| Average volume | 377.00K | 428.25K |
| Shares outstanding | 6.12M | 86.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RNTX has outperformed GOSS by 49.7 percentage points over the past year.
GOSS vs RNTX FAQ
Which is bigger, Gossamer Bio or Rein Therapeutics?
Rein Therapeutics (RNTX) is larger, with a market capitalization of $66.37M compared with $60.43M for Gossamer Bio (GOSS).
Which stock has performed better over the past year, GOSS or RNTX?
RNTX returned -45.23% over the past 12 months, compared with -94.91% for GOSS (price return, excluding dividends). Past performance does not predict future results.
Are Gossamer Bio and Rein Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.